Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DX25FVFSF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $14,407
Award facts
- Contract value 100% obligated
- $14,406.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,406.80 for XOLAIR 150 mg/ml syringes on June 2, 2025, with completion expected by June 24, 2025. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order under the Defense Logistics Agency Medical Supply Chain. The award is a child contract derived from AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.9 million through December 2026, which serves as the comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide.
XOLAIR (omalizumab) is a biologic medication used to treat severe allergic asthma and chronic spontaneous urticaria, commonly supplied to military and federal healthcare systems. This delivery order exemplifies the routine pharmaceutical procurement operations under AmerisourceBergen's prime indefinite delivery vehicle, which encompasses critical medical commodities including specialty medications, vaccines, and other therapeutic products across multiple domains. The contract's structure and pricing demonstrate the company's established capability to meet federal medical procurement requirements efficiently while supporting Defense Health Agency and other government healthcare system needs.
Quick answers
Who was awarded contract SPE2DX25FVFSF?
SPE2DX25FVFSF was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on June 2, 2025.
How much is contract SPE2DX25FVFSF worth?
The government has obligated $14,407 on SPE2DX25FVFSF.
Is contract SPE2DX25FVFSF an order under another contract?
Yes. SPE2DX25FVFSF is a delivery order under SPE2DX15D1022, an indefinite delivery contract.
Was contract SPE2DX25FVFSF competed?
The extent of competition for SPE2DX25FVFSF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award